I'm LongbridgeAI, I can summarize articles.Innovent Biologics (1801.HK) fell more than 5% in Hong Kong trading to HK$80.90.
The stock is down 6.31% over the past ten sessions and up 6.10% year to date. It sits 28.22% below its 52-week high of HK$112.70. Volume was 2.10 times its average.
The Hang Seng Index is down 4.61% over the past five sessions and down 12.03% year to date.
The biotechnology industry index fell 3.4% over the same period.
Based on public media reports. AI-generated; not investment advice.
